Alprostadil and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Alprostadil (alprostadil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have High blood pressure.

The phase IV clinical study analyzes which people have Rashes when taking Alprostadil. It is created by eHealthMe based on reports of 2,637 people who have side effects when taking Alprostadil from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Rashes?

Rashes (redness) is found to be associated with 3,713 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 21, 2026

2,637 people reported to have side effects when taking Alprostadil.
Among them, 62 people (2.35%) have Rashes.

Among these 62 people:

How long have people been on Alprostadil when they have Rashes? *

What is the gender of people who have Rashes when taking Alprostadil? *

female: 56.14 %
male: 43.86 %

What is the age of people who have Rashes when taking Alprostadil? *

What are other drugs people take besides Alprostadil? *

What are other side effects people have besides Rashes? *

Fever: 16 people, 25.81%
Constipation: 11 people, 17.74%
Renal Impairment (severely reduced kidney function): 9 people, 14.52%
Nausea (feeling of having an urge to vomit): 8 people, 12.90%
Pancreatic Enzymes Increased: 8 people, 12.90%
Purulence (containing pus): 8 people, 12.90%
Oropharyngeal Pain: 8 people, 12.90%
Acidosis (build-up of carbon dioxide in the blood): 8 people, 12.90%
High Blood Pressure: 8 people, 12.90%
Herpes Zoster: 8 people, 12.90%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 11.29%
Renal Cell Carcinoma (a kidney cancer): 5 people, 8.06%
Skin Erosion (a discontinuity of the skin): 4 people, 6.45%
Oedema (fluid collection in tissue): 3 people, 4.84%
Therapeutic Embolisation: 3 people, 4.84%
Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 3 people, 4.84%
Infusion Related Reaction: 2 people, 3.23%
Nausea (feeling of having an urge to vomit): 2 people, 3.23%
Ear Haemorrhage (bleeding from ear): 2 people, 3.23%
Carotid Artery Stenosis (narrowing of carotid artery): 2 people, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprostadil:

Alprostadil (2,653 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Alprostadil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,713 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil (the active ingredients of Alprostadil) and Alprostadil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.